Bioactive by-products
Catalog | Product Name / CAS / Description | Structure |
---|---|---|
BBF-02508 | ||
TAN-1511B is a lipopeptide antibiotic isolated from the culture broth of Streptosporangium amethystogenes subsp. fukuiense AL-23456. It induced the secretion of both granulocyte colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF). |
||
BBF-02509 | ||
TAN-1511C is a lipopeptide antibiotic isolated from the culture broth of Streptosporangium amethystogenes subsp. fukuiense AL-23456. It induced the secretion of both granulocyte colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF). |
||
BBF-02523 | ||
TMC-49A is a transcriptional up-regulator of low density lipoprotein receptor. It is produced by Streptomyces sp. AS1345. It enhanced the synthesis of LDL receptor in human hepatoma HepG2 cells as assessed by a receptor binding assay. |
||
BBF-02524 | ||
TMC-52A is a cysteine proteinase inhibitor produced by Gliocladium sp. F-2665. It strongly inhibited cysteine proteinases, in particular, cathepsin L with IC50 value of 13 nM. |
||
BBF-02525 | ||
TMC-52B is a cysteine proteinase inhibitor produced by Gliocladium sp. F-2665. It strongly inhibited cysteine proteinases, in particular, cathepsin L with IC50 value of 10 nM. |
||
BBF-02526 | ||
TMC-52C is a cysteine proteinase inhibitor produced by Gliocladium sp. F-2665. It strongly inhibited cysteine proteinases, in particular, cathepsin L with IC50 value of 10 nM. |
||
BBF-02527 | ||
TMC-52D is a cysteine proteinase inhibitor produced by Gliocladium sp. F-2665. It strongly inhibited cysteine proteinases, in particular, cathepsin L with IC50 value of 6 nM. |
||
BBF-02636 | ||
Roridin E is a macrocyclic trichothecene mycotoxin that has been found in M. verrucaria. It exhibits anticancer activity against various cancer cell lines. |
||
BBF-02712 | ||
Trichostatin RK is a trigustatine derivative produced by the strain of Streptomyces sp. RK98-A74. It can induce luciferase, but its activity is lower than that of trigustatin. |
||
BBF-02724 |
Tryprostatin B (179936-52-8) Inquiry |
|
Tryprostatin B is a natural compound isolated from Aspergillus fumigatus and arrests cell cycle progression at the G2/M phase. |
||
BBF-02726 | ||
Tuberin is produced by the strain of Str.amakusaensis 10-101 and it is resistant to mycobacteria. |
||
BBF-02738 | ||
Ustilipid A is originally isolated from Ustilago maydie DSM 11494. It has the activity of antagonizing dopamine D1 and D2 receptors with the IC50 (μg/mL) of 30 and 5, respectively. |
||
BBF-02739 | ||
Ustilipid B is originally isolated from Ustilago maydie DSM 11494. It has the activity of antagonizing dopamine D1 and D2 receptors with the IC50 (μg/mL) of 16 and 7, respectively. |
||
BBF-02755 | ||
Bu-2841-10 is a cyclic ester peptide originally isolated from K-341-B7. It has activity against gram-positive bacteria. |
||
BBF-02795 | ||
It is originally isolated from Acremonium sp. MT70646. CRM646-A had a strong inhibitory effect on the movement of B16-H10 melanoma cells with IC50 of 15 μmol/L. |
||
BBF-02796 | ||
It is originally isolated from Acremonium sp. MT70646. CRM646-B had a strong inhibitory effect on the movement of B16-H10 melanoma cells with IC50 of 30 μmol/L. |
||
BBF-02953 |
Stachybotrin A (144373-26-2) Inquiry |
|
It is produced by the strain of Stachyborrys sp. It has antimicrobial and antifungal activity. |
||
BBF-02954 |
Stachybotrin B (144385-02-4) Inquiry |
|
It is produced by the strain of Stachyborrys sp. It has antimicrobial and antifungal activity. |
||
BBF-02972 | ||
It is a trihydrofuran derivative with cytotoxicity produced by the strain of Myceliophthora lutea TF-0409. It has very weak anti-staphylococcus aureus activity. In cell culture, its cytoplasmic activity against HL 60, P388, T24, HeLa and A549 was 8-10 times weaker than adriamycin, but its cytoplasmic activity against HL 60/ADM was stronger than adriamycin (IC50 is 2.0 μg/mL). IC50 is 0.1 μg/mL. |
||
BBF-02973 | ||
It is a trihydrofuran derivative with cytotoxicity produced by the strain of Myceliophthora lutea TF-0409. It has very weak anti-staphylococcus aureus activity. In cell culture, its cytoplasmic activity against HL 60, P388, T24, HeLa and A549 was 8-10 times weaker than adriamycin, but its cytoplasmic activity against HL 60/ADM was stronger than adriamycin (IC50 is 2.0 μg/mL). IC50 is 0.2 μg/mL. |